ENDOMETRIAL CANCER AND CYP1A1, GSTM1 AND POLYMORPHISMS
子宫内膜癌与 CYP1A1、GSTM1 和多态性
基本信息
- 批准号:2801425
- 负责人:
- 金额:$ 8.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:blood chemistry cancer risk catechol methyltransferase clinical research cytochrome P450 endometrium estrogens female genetic polymorphism genotype glutathione transferase hormone related neoplasm /cancer hormone therapy human subject interview neoplasm /cancer epidemiology neoplasm /cancer genetics polymerase chain reaction restriction fragment length polymorphism smoking steroid hormone metabolism unspecific monooxygenase uterus neoplasms
项目摘要
DESCRIPTION: (Applicant's Description) Women who smoke cigarettes have
about half the risk of endometrial cancer of non-smokers. Female smokers
have been observed to have an increase in 2-hydroxylation of estrogens, and
this increased 2-hydroxylation has been suggested as a mechanism to explain
the apparent antiestrogenic effect of cigarette smoke. Polymorphisms in
several genes involved in metabolizing potential carcinogens in cigarette
smoke have been related to an increased risk of lung cancer. One of these
genes is also involved in 2-hydroxylation of estrogens. Thus, it might be
anticipated that women who have the high-risk genotypes, in terms of lung
cancer, would have a reduced risk of a condition such as endometrial cancer,
whose incidence is reduced by cigarette smoking. However, in a recent small
case-control study, a strong, positive relationship between the presence of
some of the polymorphisms in these genes and endometrial cancer risk was
reported.
In our proposed population-based case-control study, we will explore whether
polymorphisms in some of these genes are associated with endometrial cancer
risk. The genes of interest are: cytochrome P450 1A1 (CYP1A1),
glutathione-S-transferases M1 (GSTM1) and T1 (GSTT1), and
catechol-O-methyltransferase (COMT).
Cases and controls will be drawn from our funded study of continuous
combined hormone replacement therapy and endometrial cancer. Cases are
women ages 50-69 years with incident endometrial cancer diagnosed between
6/l/97 and 7/31/00, who reside in western Washington. Controls are women
recruited through random-digit dialing (ages 50-64 years) and Health Care
Financing Administration files (ages 65-69 years), who reside in the same
geographic area. In the proposed study, 175 cases and 175 controls will be
asked to provide a blood specimen at the time of interview. Using purified
DNA from these blood samples, the genotypes of interest will be assayed
using PCR and RFLPs.
Differences in the distributions of genotypes between cases and controls
will be assessed in the whole study population, as well as in sub-groups of
women defined by cigarette smoking history and use of hormone replacement
therapy (HRT). Since endometrial cancer is strongly hormone-related, the
results of this study could have relevance for other, more common cancers
whose relation to hormones is not so straightforward. Additionally, this
information potentially could be used to predict a woman's sensitivity to
the carcinogenic effects of HRT, and thus bear on a woman's decision
regarding long-term use of HRT.
描述:(申请人的描述)吸烟的妇女有
患子宫内膜癌的风险是不吸烟者的一半。 女性吸烟者
已观察到雌激素的2-羟基化增加,
这种增加的2-羟基化被认为是解释
香烟烟雾明显的抗雌激素作用。 多态性
几个参与香烟致癌物代谢的基因
吸烟与肺癌风险增加有关。 其中一
基因也参与雌激素的2-羟基化。 因此,
预计具有高风险基因型的女性,就肺功能而言,
癌症,会降低患子宫内膜癌等疾病的风险,
其发病率因吸烟而降低。 然而,在最近的一次小
病例对照研究显示,
这些基因中的一些多态性与子宫内膜癌风险之间的关系是
报道
在我们提出的基于人群的病例对照研究中,我们将探讨是否
其中一些基因的多态性与子宫内膜癌相关
风险 感兴趣的基因是:细胞色素P450 1A 1(CYP 1A 1),
谷胱甘肽-S-转移酶M1(GSTM 1)和T1(GSTT 1),和
儿茶酚-O-甲基转移酶(COMT)。
病例和对照将来自我们资助的持续性研究,
联合激素替代疗法和子宫内膜癌。 案件
年龄50-69岁的女性,诊断为子宫内膜癌,
1997年6月1日和2000年7月31日,居住在华盛顿西部。 对照组为女性
通过随机数字拨号(年龄50-64岁)和医疗保健招募
财务管理档案(年龄65-69岁),居住在同一个
地理区域。 在拟议的研究中,将有175例病例和175例对照,
在面试时被要求提供血液样本。 使用纯化
从这些血液样本的DNA中,将测定感兴趣的基因型
使用PCR和RFLP。
病例组与对照组基因型分布的差异
将在整个研究人群以及以下亚组中进行评估
根据吸烟史和使用激素替代品定义的女性
激素替代疗法(HRT)。 由于子宫内膜癌是强烈相关的,
这项研究的结果可能与其他更常见的癌症有关
它与荷尔蒙的关系并不简单。 而且这个
这些信息可能被用来预测一个女人对
激素替代疗法的致癌作用,从而影响妇女的决定
长期使用激素替代疗法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHU S CHEN其他文献
CHU S CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHU S CHEN', 18)}}的其他基金
COBRE: LSU:PROJ 4:CYCLOOXYGENASES IN NEURONAL SYNAPTIC PLASTICITY
COBRE:LSU:项目 4:神经元突触可塑性中的环加氧酶
- 批准号:
7959417 - 财政年份:2009
- 资助金额:
$ 8.65万 - 项目类别:
COBRE: LSU:PROJ 4:CYCLOOXYGENASES IN NEURONAL SYNAPTIC PLASTICITY
COBRE:LSU:项目 4:神经元突触可塑性中的环加氧酶
- 批准号:
7719904 - 财政年份:2008
- 资助金额:
$ 8.65万 - 项目类别:
COBRE: LSU:PROJ 4:CYCLOOXYGENASES IN NEURONAL SYNAPTIC PLASTICITY
COBRE:LSU:项目 4:神经元突触可塑性中的环加氧酶
- 批准号:
7610407 - 财政年份:2007
- 资助金额:
$ 8.65万 - 项目类别:
COBRE: LSU:PROJ 4:CYCLOOXYGENASES IN NEURONAL SYNAPTIC PLASTICITY
COBRE:LSU:项目 4:神经元突触可塑性中的环加氧酶
- 批准号:
7381794 - 财政年份:2006
- 资助金额:
$ 8.65万 - 项目类别:
COBRE: LSU:PROJ 4:CYCLOOXYGENASES IN NEURONAL SYNAPTIC PLASTICITY
COBRE:LSU:项目 4:神经元突触可塑性中的环加氧酶
- 批准号:
7171014 - 财政年份:2005
- 资助金额:
$ 8.65万 - 项目类别:
COBRE: LSU:CYCLOOXYGENASES IN NEURONAL SYNAPTIC P
COBRE:LSU:神经元突触 P 中的环加氧酶
- 批准号:
6981697 - 财政年份:2004
- 资助金额:
$ 8.65万 - 项目类别:
ENDOGENOUS SEX HORMONES, GENETICS, AND PROSTATE CANCER
内源性激素、遗传学和前列腺癌
- 批准号:
6377206 - 财政年份:1999
- 资助金额:
$ 8.65万 - 项目类别:
ENDOGENOUS SEX HORMONES, GENETICS, AND PROSTATE CANCER
内源性激素、遗传学和前列腺癌
- 批准号:
6174162 - 财政年份:1999
- 资助金额:
$ 8.65万 - 项目类别:
相似海外基金
Urinary Phthalate Biomarker Concentrations and Breast and Prostate Cancer Risk in a National Cohort of Adults in Canada
加拿大全国成人队列中尿液邻苯二甲酸盐生物标志物浓度与乳腺癌和前列腺癌风险
- 批准号:
494953 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Operating Grants
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
- 批准号:
10912190 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
- 批准号:
10805177 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
开发患者特异性癌症风险和早期肿瘤发生的诊断方法
- 批准号:
478999 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Operating Grants
Environmental Metal Exposures and Breast Cancer Risk: A Prospective Study of Nationally Representative Canadian Data
环境金属暴露与乳腺癌风险:加拿大全国代表性数据的前瞻性研究
- 批准号:
495159 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
- 批准号:
10650054 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
影响减肥手术后结直肠癌风险的肠道微生物相关机制
- 批准号:
10733566 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?
肥胖、身体脂肪分布和乳腺癌风险:内脏脂肪是绝经后的罪魁祸首吗?
- 批准号:
10586626 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:
Optimization of a personalized skin cancer risk intervention for at-risk young adults
针对高危年轻人的个性化皮肤癌风险干预措施的优化
- 批准号:
10582944 - 财政年份:2023
- 资助金额:
$ 8.65万 - 项目类别:














{{item.name}}会员




